US Senator Jim Banks has urged the FDA to strengthen inspections of overseas pharmaceutical manufacturing facilities, raising concerns over poor-quality drugs from India and China.
Al Ngullie
2025-10-17 12:28:35
Be the first to receive special offers and the latest news.